Global Romiplostim Market to Reach USD 2.75 Billion by 2034 Driven by Rising ITP Cases
According to a new report from Intel Market Research, the global Romiplostim market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2026-2034). This growth trajectory reflects the rising global burden of chronic immune thrombocytopenia (ITP) and increasing adoption of targeted biologic...
0 التعليقات 0 المشاركات 123 مشاهدة 0 معاينة